Track funded biotech companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17 Nov 2026 | Isomorphic Labs IsoDDE is a unified drug design engine that uses AI and simulation models t... | £3,800,000,000 | |||||||||||
16 Nov 2026 | TileBio TileBio provides a machine learning model trained on unlabelled histology i... | £2,261,000 | |||||||||||
16 Nov 2026 | Zya Convero is a dry powdered enzyme ingredient formulated for inclusion in low... | £11,350,000 US$15,000,000 | |||||||||||
10 Nov 2026 | Neobe Neobe develops engineered bacteria that colonise tumours and release enzyme... | £5,060,000 US$6,800,000 | |||||||||||
10 Nov 2026 | Oyster Therapeutics Oyster Therapeutics develops an oral tau degrader using its SELFTAC platfor... | £44,680,000 US$60,000,000 | |||||||||||
9 Nov 2026 | PhaSER Biomedical PhaSER Biomedical offers the 8HUM humanised mouse platform and supporting c... | £2,000,000 | |||||||||||
6 Nov 2026 | bio.bit bio.bit supplies human cell models and an opti-ox platform that programs ce... | £18,570,000 US$25,000,000 | |||||||||||
5 Nov 2026 | FluoRok A manufacturing platform that produces fluorochemicals without hydrogen flu... | £22,270,000 US$30,000,000 | |||||||||||
5 Nov 2026 | T-Therapeutics T-Therapeutics develops therapies that use a platform to supply fully human... | £100,000,000 | |||||||||||
5 Nov 2026 | Alethio Therapeutics ATX-011 is a monoclonal antibody that binds a disease-associated cell surfa... | £67,000,000 | |||||||||||
5 Nov 2026 | Potential Sciences Potential Sciences offers a software platform that generates large-scale qu... | ||||||||||||
3 Nov 2026 | Bioliberty Lifeglov is a soft-robotic glove paired with AI that supports physical reha... | £7,700,000 | |||||||||||
3 Nov 2026 | OSSTEC ASCENT is a cementless partial knee implant made using 3D-printed component... | £5,970,000 US$8,000,000 | |||||||||||
3 Nov 2026 | Viridi Vireya is an anionic surfactant made from captured carbon dioxide using Vir... | £2,200,000 | |||||||||||
26 Oct 2026 | imphatec A small implant placed under the skin that steadily releases medication ove... | £1,500,000 | |||||||||||
16 Oct 2026 | Microbiotica MB310 is an oral once-daily live biotherapeutic capsule containing eight sp... | £36,000,000 | |||||||||||
16 Oct 2026 | Medcotec The Helyx valve is a single-use, full-bore powder transfer valve for pharma... | £2,400,000 | |||||||||||
16 Oct 2026 | OMass Therapeutics OMS1620 is a small-molecule drug that binds the MC2 receptor to modify rece... | £233,750,000 US$310,000,000 | |||||||||||
14 Oct 2026 | HydRegen HydRegen provides a bio-based hydrogenation platform that formulates enzyme... | £6,040,000 US$8,000,000 | |||||||||||
13 Oct 2026 | Undecimal Bio DELiveri is a platform that uses chemical screening and machine learning to... | £14,000,000 | |||||||||||
12 Oct 2026 | Sava Technologies Sava Technologies offers a wearable glucose microsensor that measures gluco... | £27,000,000 | |||||||||||
8 Oct 2026 | Neela Biotech A process using AI to guide microbial communities that convert organic wast... | £2,100,000 | |||||||||||
6 Oct 2026 | Sensible Biotechnologies A cell-based platform that produces naturally modified mRNA using engineere... | £35,550,000 US$47,000,000 | |||||||||||
29 Sept 2026 | 52North Neutrocheck is a rapid finger prick blood test that uses a biomarker detect... | £3,200,000 | |||||||||||
24 Sept 2026 | Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
18 Sept 2026 | Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 | Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 | MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | |||||||||||
17 Sept 2026 | Eterna Regeneratives A keratin scaffold that forms a thin layer on tooth and bone surfaces. It i... | ||||||||||||
16 Sept 2026 | Axo Longevity Axo Longevity is a membership service that provides regular blood panels, a... | £3,710,000 US$5,000,000 |

1 Explore 284 UK biotech startups and their founders, who have collectively raised £9.36B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing biotech startups with the full list of recently funded startups from the UK.
Cambridge has always been a major hotspot for Biotech startups but London is now fighting back hard to compensate for the WFH (work from home) trend in finance. In Canary Wharf, a new 23-story life science tower has even been approved!
The UK has developed one of Europe's strongest biotech ecosystems, centred around research universities in London, Cambridge, Oxford, Manchester and Edinburgh. This list highlights funded biotech startups across pre-seed, seed and later rounds.
Biotech in this context covers therapeutics, diagnostics, synthetic biology, bioinformatics, industrial biotech and environmental applications. Many of these companies combine scientific research with software, data and AI to accelerate development and improve decision-making in clinical or industrial settings.
Use this page to explore the fastest growing biotech startups in the UK, then review individual profiles for websites, investors, locations and recent funding. For filters, exports and deeper analysis, you can upgrade to full database access.
That’s for the fastest growing biotech startups. If you're looking for funding opportunities, check out our list of top biotech investors backing innovative startups.
Biotech, short for biotechnology, is a field of science and technology that involves the use of living organisms, cells, and biological systems to develop and create products or applications that benefit various industries.
It combines biology, chemistry, genetics, and other disciplines to manipulate biological systems for practical purposes. Biotechnology has a wide range of applications, including medicine, agriculture, food production, and environmental management.
Key areas of biotechnology include:
Involves the development of pharmaceuticals, vaccines, and diagnostic tools. It also includes gene therapy, where genetic material is used to treat or prevent diseases.
Focuses on improving crop yield, resistance to pests and diseases, and enhancing nutritional content. Genetically modified organisms (GMOs) are an example of agricultural biotechnology.
Utilises biological systems to produce chemicals, fuels, and other industrial products. This can include the use of microorganisms for fermentation processes.
Addresses environmental issues by developing technologies for waste treatment, pollution control, and sustainable resource management.
Involves the use of computer science and information technology to analyse biological data, such as DNA sequences and protein structures.
Biotechnology has the potential to revolutionise various industries and improve the quality of life by offering innovative solutions to complex problems. And we haven’t talked about how AI will also impact this race.
The UK has a fantastic opportunity to reinforce its current position and grow into a world leader for biotech startups.
Biotech startups are companies developing products or technologies using biology, genetics, pharmaceuticals, diagnostics or life sciences research. UK biotech startups commonly operate across therapeutics, synthetic biology, drug discovery, diagnostics, genomics, precision medicine and AI-powered life sciences.
The UK has one of the strongest biotech ecosystems in Europe because of its universities, NHS-linked research infrastructure, scientific talent and specialist life sciences investors. Cambridge, Oxford and London are especially important for biotech spinouts, venture funding and commercialisation.
Biotech startups in the UK typically raise funding through angel investors, venture capital firms, university spinout funds, Innovate UK grants and strategic partnerships. Many biotech companies need larger and longer funding pathways than software startups because of laboratory work, clinical validation and regulation.
A biotech spinout is a startup commercialising scientific research developed within a university, laboratory or research institution. Many UK biotech spinouts originate from institutions such as the University of Cambridge, the University of Oxford, Imperial College London and other research centres.
Biotech startups often take longer to scale because they must prove scientific validity, navigate regulation, run trials or validation studies and reach commercial partnerships. Investors usually expect longer timelines, larger capital requirements and deeper technical risk than in many software markets.